E.U. Sumer

592 citations

12 papers · 497 indexed · h-index 10

Impact in

Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
Immunology and Allergy top 10%
- Cell Adhesion Molecules Research

Papers in ⓘ

Rheumatology 9
- Osteoarthritis Treatment and Mechanisms 7
- Rheumatoid Arthritis Research and Therapies 4
Cancer Research 5
- Protease and Inhibitor Mechanisms 5

Co-authors: M.A. Karsdal (7 shared papers)Per Qvist (7 shared papers)B.C. Søndergaard (5 shared papers)László B. Tankó (3 shared papers)Kevin L. Duffin (1 shared paper)Dennis A. Laska (1 shared paper)Isabelle J. Brittain (1 shared paper)Peter G. Mitchell (1 shared paper)
Journals: Osteoarthritis and Cartilage (3 papers)Biomarkers (2 papers)Assay and Drug Development Technologies (1 paper)Journal of Bacteriology (1 paper)FEBS Journal (1 paper)
Partner nations: Denmark United States Australia

In The Last Decade

E.U. Sumer

11 papers receiving 484 citations

Peers

Countries citing papers authored by E.U. Sumer

Since Specialization

Citations

This map shows the geographic impact of E.U. Sumer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.U. Sumer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.U. Sumer more than expected).

Fields of papers citing papers by E.U. Sumer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.U. Sumer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.U. Sumer. The network helps show where E.U. Sumer may publish in the future.

Co-authors

The 25 scholars most cited alongside E.U. Sumer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.U. Sumer Line = papers co-authored together E.U. Sumer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Characterization of metalloprotease cleavage products of human articular cartilage Arthritis & Rheumatism ·Yuejun Zhen, Isabelle J. Brittain, Dennis A. Laska, Peter G. Mitchell, E.U. Sumer, M.A. Karsdal, Kevin L. Duffin	2008	131
2	In Vitro, Ex Vivo , and In Vivo Methodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers Can Assist? Assay and Drug Development Technologies ·Sophie Schaller, Kim Henriksen, Pernille Høegh-Andersen, B.C. Søndergaard, E.U. Sumer, László B. Tankó, Per Qvist, M.A. Karsdal	2005	93
3	Epidermal growth factor receptor ligands as new extracellular targets for the metastasis‐promoting S100A4 protein FEBS Journal ·Jörg Klingelhöfer, Henrik Devitt Møller, E.U. Sumer, Christian Hededam Berg, Maria Poulsen, Darya Kiryushko, Vladislav Soroka, Noona Ambartsumian, Mariam Grigorian, Eugene Lukanidin	2009	73
4	Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase–mediated cartilage degradation, but not aggrecanase‐mediated cartilage degradation Arthritis & Rheumatism ·M.A. Karsdal, E.U. Sumer, Helle Wulf, S.H. Madsen, Claus Christiansen, Amanda Fosang, Bodil-Cecilie Sondergaard	2007	59
5	MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays Osteoarthritis and Cartilage ·E.U. Sumer, B.C. Søndergaard, Jean‐Charles Rousseau, Pierre D. Delmas, Amanda Fosang, M.A. Karsdal, Claus Christiansen, Per Qvist	2006	50
6	Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in timeex vivo Biomarkers ·S.H. Madsen, E.U. Sumer, Anne‐Christine Bay‐Jensen, Bodil-Cecilie Sondergaard, Per Qvist, M.A. Karsdal	2009	25
7	Matrix metalloproteinase and aggrecanase generated aggrecan fragments: implications for the diagnostics and therapeutics of destructive joint diseases Drug Development Research ·E.U. Sumer, Per Qvist, László B. Tankó	2007	20
8	Patients with rheumatoid arthritis have an altered circulatory aggrecan profile BMC Musculoskeletal Disorders ·Jean C Rousseau, E.U. Sumer, Gert Hein, Bodil C Sondergaard, S.H. Madsen, Christian E. Pedersen, Thomas Neumann, Andreas Mueller, Per Qvist, Pierre Delmas, M.A. Karsdal	2008	18
9	Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review Biomarkers ·E.U. Sumer, Sophie Schaller, B.C. Søndergaard, László B. Tankó, Per Qvist	2006	15
10	Implication of Proteins Containing Tetratricopeptide Repeats in Conditional Virulence Phenotypes of Legionella pneumophila Journal of Bacteriology ·Purnima Bandyopadhyay, E.U. Sumer, Deepak Jayakumar, Shuqing Liu, Huifang Xiao, Howard M. Steinman	2012	12
11	206 CARTILAGE DEGRADATION IS FULLY REVERSIBLE IN THE PRESENCE OF AGGRECANASE BUT NOT MATRIX METALLOPROTEINASE ACTIVITY Osteoarthritis and Cartilage ·M.A. Karsdal, Sofie Falkenløve Madsen, E.U. Sumer, Claus Christiansen, Amanda Fosang, B.C. Søndergaard	2007	1
12	P85 INTERLEUKIN-1 ALPHA IN COMPARISON TO INTERLEUKIN-1 BETA IS A MORE POTENT STIMULATOR OF AGGRECANASE MEDIATED AGGRECAN DEGRADATION IN HUMAN ARTICULAR CARTILAGE Osteoarthritis and Cartilage ·E.U. Sumer, B.C. Søndergaard, S.H. Madsen, Per Qvist, M.A. Qvist	2006	0

About E.U. Sumer

E.U. Sumer is a scholar working on Rheumatology, Cancer Research, Immunology and Allergy, Molecular Biology and Pharmacology, having authored 12 papers that have together received 497 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Protease and Inhibitor Mechanisms (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Cell Adhesion Molecules Research (3 papers), Proteoglycans and glycosaminoglycans research (2 papers), Inflammatory mediators and NSAID effects (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper) and Bone health and osteoporosis research (1 paper). The work is most often cited by research in Rheumatology (244 citations), Immunology and Allergy (78 citations), Cancer Research (138 citations), Pharmacology (96 citations) and Orthopedics and Sports Medicine (32 citations). E.U. Sumer has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include M.A. Karsdal, Per Qvist, B.C. Søndergaard, László B. Tankó, Kevin L. Duffin, Dennis A. Laska, Isabelle J. Brittain, Peter G. Mitchell, Yuejun Zhen and Amanda Fosang. Their work appears in journals such as Osteoarthritis and Cartilage, Biomarkers, Assay and Drug Development Technologies, Journal of Bacteriology and FEBS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact